Dr. Agarwal's Health Care

386.50
-2.95
(-0.76%)
Market Cap
12,208.76 Cr
EPS
3.14
PE Ratio
137.24
Dividend Yield
0.00 %
Industry
0.00
52 Week High
464.00
52 Week Low
361.10
PB Ratio
6.82
Debt to Equity
0.93
Sector
0.00
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from3 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+66.67 %
+66.67 %
Hold
Hold+33.33 %
+33.33 %
Sell
Sell0.0 %
0.0 %
Growth Rate
Revenue Growth
33.44 %
Net Income Growth
-7.85 %
Cash Flow Change
48.41 %
ROE
-56.00 %
ROCE
-1.67 %
EBITDA Margin (Avg.)
7.34 %

Quarterly Financial Results

Quarterly Financials
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
345
369
410
429
443
Expenses
244
242
300
310
316
EBITDA
101
127
110
119
128
Operating Profit %
27 %
31 %
26 %
26 %
27 %
Depreciation
43
46
56
57
58
Interest
22
27
27
28
28
Profit Before Tax
36
54
27
33
41
Tax
13
13
9
12
13
Net Profit
23
41
18
21
28
EPS in ₹
1.94
41.53
0.39
0.45
0.73

Balance Sheet

Balance Sheet
2022
2023
2024
Total Assets
1,026
1,825
2,753
Fixed Assets
702
1,293
1,746
Current Assets
228
310
759
Capital Work in Progress
28
99
118
Investments
0
34
471
Other Assets
296
399
418
Total Liabilities
1,026
1,825
2,753
Current Liabilities
206
301
400
Non Current Liabilities
586
865
974
Total Equity
234
659
1,380
Reserve & Surplus
206
622
1,330
Share Capital
7
8
9

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
Net Cash Flow
-56
17
44
27
-15
Investing Activities
-85
-46
-155
-509
-914
Operating Activities
103
99
164
233
346
Financing Activities
-74
-37
35
303
553

Share Holding

% Holding
Sept 2024
Jan 2025
Feb 2025
Mar 2025
Promoter
37.83 %
37.73 %
32.45 %
32.45 %
FIIs
0.00 %
0.00 %
56.97 %
60.62 %
DIIs
0.00 %
0.00 %
5.10 %
5.21 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
4.79 %
1.61 %
Others
62.17 %
62.27 %
0.69 %
0.11 %
No of Share Holders
29
43
2,17,289
68,696

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Announcements

Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS6 days ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 03, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 03, 2025
Commencement Of Operations Of New Branch - EluruMar 27, 2025
Closure of Trading WindowMar 27, 2025
Commencement Of Operations Of A New Branch - UdhnaMar 24, 2025
Commencement Of Operations Of A New Branch - DombivliMar 21, 2025
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015Mar 17, 2025
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015Mar 13, 2025
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015Mar 13, 2025
Commencement Of Operations Of A New Branch - GopalpatnamMar 12, 2025
Commencement Of Operations Of A New Branch - KarimnagarMar 10, 2025
Commencement Of Operations Of A New Branch - VirarMar 08, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 07, 2025
Commencement Of Operations Of New Branches - Mysore And SiddipetMar 06, 2025
Commencement Of Operations Of A New Branch - JaunpurMar 03, 2025
Commencement Of Operations Of A New BranchFeb 27, 2025
Commencement Of Operations Of A New BranchFeb 27, 2025
Commencement Of Operations Of A New BranchFeb 24, 2025
Commencement Of Operations Of A New BranchFeb 21, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 20, 2025
Commencement Of Operation Of A New BranchFeb 19, 2025
Announcement under Regulation 30 (LODR)-Credit RatingFeb 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 17, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 17, 2025
Integrated Filing (Financial)Feb 15, 2025
Board Meeting Outcome for Outcome Of Board Meeting For Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31 2024Feb 14, 2025
Results - Quarter And Nine Months Ended December 31 2024Feb 14, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Feb 14, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 12, 2025
Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31 2024Feb 11, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Feb 07, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Feb 06, 2025
Closure of Trading WindowFeb 04, 2025
Listing of Equity Shares of Dr. Agarwals Health Care LtdFeb 04, 2025

Technical Indicators

RSI(14)
Neutral
34.63
ATR(14)
Less Volatile
18.99
STOCH(9,6)
Neutral
30.74
STOCH RSI(14)
Oversold
2.21
MACD(12,26)
Bearish
-4.45
ADX(14)
Strong Trend
25.98
UO(9)
Bearish
44.31
ROC(12)
Downtrend And Accelerating
-10.97
WillR(14)
Neutral
-69.53